Publish date:

April 2007

<I>TheStreet.com</I> corrects its errors.
Author:

The April 26 edition of TheStreet.com's Dividend Stock Advisor contained two errors regarding United Online's (UNTD) earnings history. The subscription newsletter said the company's first-quarter earnings would be down 41% year over year, but that compared GAAP estimates for this year with non-GAAP results of a year ago.

On a GAAP to GAAP basis, the earnings will be down 20% year over year. The same edition said the company had missed analyst expectations three quarters in a row. In fact, in the most recent quarter, the company had a noncash writedown that caused it to miss GAAP expectations for earnings per share, but it has met non-GAAP expectations in each of the last three quarters.

TheStreet.com

regrets the errors.

(Corrected May 1)

An April 24 story titled

BofA May Prune Branches contained a sentence stating that "Bank of America's purchase of LaSalle is not necessarily a done deal." The sentence should have read: "Barclays' acquisition of ABN-Amro is not necessarily a done deal."

TheStreet.com

regrets the error.

(Corrected April 24)

An April 23 column titled

Bask in Heat of Steel Valuations contained an editing error; the column stated that

PDL BioPharma

(PDLI:Nasdaq) shares were rising because of the deal for

MedImmune

(MEDI:Nasdaq). It should have indicated that biopharma stocks as a group were rising.

TheStreet.com

regrets the error.

(Corrected April 23)

A table in an April 21 story titled

Real Estate's Quarter Turns to Quicksand should have included the

(IRFAX) - Get Cohen & Steers Intl Realty A Report

Cohen & Steers International Realty Fund (IRFAX) as the eighth-ranked fund on the top-10 list.

An April 20 item,

Studies Pep Up EpiCept, misstated the nature of a licensing agreement between

EpiCept

(EPCT) and

Myriad Genetics

(MYGN). EpiCept licensed the brain tumor drug Azixa to Myriad, not from Myriad.

TheStreet.com

regrets the error.

(Corrected April 20)

An April 19 column on

RealMoney.com

titled

Dollar Index Nears Its Target incorrectly stated that it takes $1 to purchase two British pounds. It should have indicated the reverse, that one pound sterling costs $2.

TheStreet.com

regrets the error.

(Corrected April 19)

An April 18 report,

Wednesday's Late Winners & Losers, contained an incorrect stock price for

TheStreet Recommends

First Horizon National

(FHN). The stock had fallen in after-hours trading Wednesday by 3.2% to $39.90, not $29.90. Also, the bank is based in Tennessee, not Florida.

TheStreet.com

regrets the errors.

(Corrected April 19)

A May 31, 2006, article,

World Cup Fever, written by a freelance writer as a "Good Life" feature on

TheStreet.com

, appears to have appropriated material from a

travel feature originally published on the Guardian Unlimited Web site in the U.K. on Dec. 21, 2005.

TheStreet.com

considers the incident a serious breach of its standards, and apologizes for its publication. The company has ended its relationship with the writer.

(Corrected April 18)

On an April 12 edition of Wall St. Confidential,

Finding the Next Dendreon

, George Moriarty said Dendreon CEO Mitch Gold sold 2.2 million shares of the company's stock on April 2. In fact, he sold $2.2 million in stock. TheStreet.com regrets the error.

(Corrected April 13)

An April 10 blog post,

Get Real About Real Estate, misstated the number of acres in a square mile. It is 640, not 560, as originally published.

TheStreet.com

regrets the error.

(Corrected April 10)

An April 9 blog post,

Neurochem Isn't the Next Dendreon, erroneously reported that the company is expected to get news about a trial of Alzheimer's treatment eprodisate. However, tramiprosate is the company's Alzheimer's treatment candidate, for which Neurochem expects to release top-line results from its North American phase III clinical trial this spring. Eprodisate is an investigational candidate for the treatment of Amyloid A amyloidosis.

TheStreet.com

regrets the error.

(Corrected April 10)

The headline in an April 5 report,

Thursday's Buybacks: Community Valley Bancorp for $6 Million, originally contained a wrong amount of stock being bought back by

Community Valley Bancorp

(CVLL). It is $6 million, not $600 million.

TheStreet.com

regrets the error.

(Corrected April 9)

A March 29 column by Jim Cramer titled

Cheap, Good, Juicy: Freeport-McMoRan contained an error. The Cuban mine that

Freeport

(FCX) had an interest in produces nickel, not copper.

TheStreet.com

regrets the error.

(Corrected April 3)